423 related articles for article (PubMed ID: 32247802)
1. IN VITRO AND IN VIVO MODELS OF AMYOTROPHIC LATERAL SCLEROSIS: AN UPDATED OVERVIEW.
Gois AM; Mendonça DMF; Freire MAM; Santos JR
Brain Res Bull; 2020 Jun; 159():32-43. PubMed ID: 32247802
[TBL] [Abstract][Full Text] [Related]
2. Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations.
Jeon GS; Shim YM; Lee DY; Kim JS; Kang M; Ahn SH; Shin JY; Geum D; Hong YH; Sung JJ
Mol Neurobiol; 2019 Mar; 56(3):2007-2021. PubMed ID: 29982983
[TBL] [Abstract][Full Text] [Related]
3. Rodent Models of Amyotrophic Lateral Sclerosis.
Philips T; Rothstein JD
Curr Protoc Pharmacol; 2015 Jun; 69():5.67.1-5.67.21. PubMed ID: 26344214
[TBL] [Abstract][Full Text] [Related]
4. Dysregulation of AMPA receptor subunit expression in sporadic ALS post-mortem brain.
Gregory JM; Livesey MR; McDade K; Selvaraj BT; Barton SK; Chandran S; Smith C
J Pathol; 2020 Jan; 250(1):67-78. PubMed ID: 31579943
[TBL] [Abstract][Full Text] [Related]
5. From Mouse Models to Human Disease: An Approach for Amyotrophic Lateral Sclerosis.
Alrafiah AR
In Vivo; 2018; 32(5):983-998. PubMed ID: 30150420
[TBL] [Abstract][Full Text] [Related]
6. The Overexpression of TDP-43 Protein in the Neuron and Oligodendrocyte Cells Causes the Progressive Motor Neuron Degeneration in the SOD1 G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.
Lu Y; Tang C; Zhu L; Li J; Liang H; Zhang J; Xu R
Int J Biol Sci; 2016; 12(9):1140-9. PubMed ID: 27570488
[TBL] [Abstract][Full Text] [Related]
7. Estimated Prevalence and Incidence of Amyotrophic Lateral Sclerosis and SOD1 and C9orf72 Genetic Variants.
Brown CA; Lally C; Kupelian V; Flanders WD
Neuroepidemiology; 2021; 55(5):342-353. PubMed ID: 34247168
[TBL] [Abstract][Full Text] [Related]
8. Novel Pathogenic Variants Leading to Sporadic Amyotrophic Lateral Sclerosis in Greek Patients.
Ivantsik O; John A; Kydonopoulou K; Mitropoulos K; Gerou S; Ali BR; Patrinos GP
Genes (Basel); 2024 Feb; 15(3):. PubMed ID: 38540370
[TBL] [Abstract][Full Text] [Related]
9. Oligodendrocytes contribute to motor neuron death in ALS via SOD1-dependent mechanism.
Ferraiuolo L; Meyer K; Sherwood TW; Vick J; Likhite S; Frakes A; Miranda CJ; Braun L; Heath PR; Pineda R; Beattie CE; Shaw PJ; Askwith CC; McTigue D; Kaspar BK
Proc Natl Acad Sci U S A; 2016 Oct; 113(42):E6496-E6505. PubMed ID: 27688759
[TBL] [Abstract][Full Text] [Related]
10. Single copy/knock-in models of ALS SOD1 in C. elegans suggest loss and gain of function have different contributions to cholinergic and glutamatergic neurodegeneration.
Baskoylu SN; Yersak J; O'Hern P; Grosser S; Simon J; Kim S; Schuch K; Dimitriadi M; Yanagi KS; Lins J; Hart AC
PLoS Genet; 2018 Oct; 14(10):e1007682. PubMed ID: 30296255
[TBL] [Abstract][Full Text] [Related]
11. Editor's Highlight: Embryonic Exposure to the Environmental Neurotoxin BMAA Negatively Impacts Early Neuronal Development and Progression of Neurodegeneration in the Sod1-G93R Zebrafish Model of Amyotrophic Lateral Sclerosis.
Powers S; Kwok S; Lovejoy E; Lavin T; Sher RB
Toxicol Sci; 2017 May; 157(1):129-140. PubMed ID: 28123103
[TBL] [Abstract][Full Text] [Related]
12. SOD1 in neurotoxicity and its controversial roles in SOD1 mutation-negative ALS.
Hayashi Y; Homma K; Ichijo H
Adv Biol Regul; 2016 Jan; 60():95-104. PubMed ID: 26563614
[TBL] [Abstract][Full Text] [Related]
13. Could Sirtuin Activities Modify ALS Onset and Progression?
Tang BL
Cell Mol Neurobiol; 2017 Oct; 37(7):1147-1160. PubMed ID: 27942908
[TBL] [Abstract][Full Text] [Related]
14. Does wild-type Cu/Zn-superoxide dismutase have pathogenic roles in amyotrophic lateral sclerosis?
Furukawa Y; Tokuda E
Transl Neurodegener; 2020 Aug; 9(1):33. PubMed ID: 32811540
[TBL] [Abstract][Full Text] [Related]
15. Limited corticospinal tract involvement in amyotrophic lateral sclerosis subjects with the A4V mutation in the copper/zinc superoxide dismutase gene.
Cudkowicz ME; McKenna-Yasek D; Chen C; Hedley-Whyte ET; Brown RH
Ann Neurol; 1998 Jun; 43(6):703-10. PubMed ID: 9629839
[TBL] [Abstract][Full Text] [Related]
16. Characterizing the multiple roles of FGF-2 in SOD1
Kefalakes E; Böselt S; Sarikidi A; Ettcheto M; Bursch F; Naujock M; Stanslowsky N; Schmuck M; Barenys M; Wegner F; Grothe C; Petri S
J Cell Physiol; 2019 May; 234(5):7395-7410. PubMed ID: 30370540
[TBL] [Abstract][Full Text] [Related]
17. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex.
Thomsen GM; Gowing G; Latter J; Chen M; Vit JP; Staggenborg K; Avalos P; Alkaslasi M; Ferraiuolo L; Likhite S; Kaspar BK; Svendsen CN
J Neurosci; 2014 Nov; 34(47):15587-600. PubMed ID: 25411487
[TBL] [Abstract][Full Text] [Related]
18. Pathogenic Genome Signatures That Damage Motor Neurons in Amyotrophic Lateral Sclerosis.
Yousefian-Jazi A; Seol Y; Kim J; Ryu HL; Lee J; Ryu H
Cells; 2020 Dec; 9(12):. PubMed ID: 33333804
[TBL] [Abstract][Full Text] [Related]
19. Compartment specific mitochondrial dysfunction in Drosophila knock-in model of ALS reversed by altered gene expression of OXPHOS subunits and pro-fission factor Drp1.
Nemtsova Y; Steinert BL; Wharton KA
Mol Cell Neurosci; 2023 Jun; 125():103834. PubMed ID: 36868541
[TBL] [Abstract][Full Text] [Related]
20. Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent.
Fujimori K; Ishikawa M; Otomo A; Atsuta N; Nakamura R; Akiyama T; Hadano S; Aoki M; Saya H; Sobue G; Okano H
Nat Med; 2018 Oct; 24(10):1579-1589. PubMed ID: 30127392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
